Ben Atwell

United KingdomUnited Kingdom

PublicScheme

target

Shire

bidder

Takeda Pharmaceutical Company

£44,4b

dealmakers

PublicAcquisitionSchemeMajority

target

Sinclair Pharma

bidder

Huadong Medicine Co

£179m

dealmakers

AcquisitionPublicSchemeMajorityPrivate Equity

target

Btg

bidder

Boston Scientific Corporation

£3b

dealmakers

PrivateAcquisitionMajority

Medical Equipment

target

Ceterix Orthopaedics

bidder

Smith & Nephew

£82m

dealmakers

PublicAcquisition

target

Osiris Therapeutics

bidder

Smith & Nephew

£505m

dealmakers

AcquisitionPrivateMajority

Medical Equipment

target

Leaf Healthcare

bidder

Smith & Nephew

value n/a

dealmakers

Switzerland

Private EquityAcquisitionPrivateMajorityCross Border

target

Nestle Skin Health

bidder

Eqt Partners

£7,7b

dealmakers

Germany

AcquisitionPrivateMajorityDomestic

target

Brainlab (orthopaedic Joint Reconstruction Business)

bidder

Smith & Nephew

value n/a

dealmakers

Medical Services

PrivateAcquisition

target

Blue Earth Diagnostics

bidder

Bracco Imaging

£390m

dealmakers

Germany

PrivateAcquisitionMajority

target

Expedeon (proteomics And Immunology Business)

bidder

Abcam

£103m

dealmakers

AcquisitionPublicMajorityPrivatisationCross Border

target

Consort Medical

bidder

Recipharm

£627m

dealmakers

Private EquityAcquisitionPrivate

target

Achilles Therapeutics

bidder

Syncona

£100m

dealmakers

AcquisitionMinorityPublic

target

Karuna Therapeutics

bidder

Goldman Sachs

£152m

dealmakers

AcquisitionPrivateMinorityPrivate Equity

target

Azeria Therapeutics

bidder

Sixth Element Capital

£32m

dealmakers

PrivateMajorityAcquisition

target

Marker Gene Technologies

bidder

Abcam

value n/a

dealmakers

PublicAcquisitionPrivate EquityMinority

target

Hutchison China Meditech

bidder

General Atlantic

£80m

dealmakers

Customer Relationship Management

MajorityAcquisitionPublicPrivate EquityDomestic

target

Cello Health

bidder

Arsenal Capital Partners

£181m

dealmakers

PublicPrivate EquityAcquisitionCross BorderMinority

target

Hutchison China Meditech

bidder

Canada Pension Plan Investment Board

£75m

dealmakers

Switzerland

Cross BorderPrivateAcquisitionMajority

target

Om Pharma

bidder

Optimus Holding

£369m

dealmakers

PrivateAcquisitionCross BorderMajorityPrivate Equity

target

Hutchison China Meditech

bidder

Canada Pension Plan Investment Board

£75m

dealmakers

PublicVenture CapitalPrivate EquityAcquisitionDomesticMinority

target

Abcam

bidder

Durable Capital Partners

£110m

dealmakers

MergerPublicMajorityAcquisitionCross Border

target

Gw Pharmaceuticals

bidder

Jazz Pharmaceuticals

£5,5b

dealmakers

PrivateMajorityCross BorderAcquisition

Medical Services

target

Radmd

bidder

Medica Group

£15m

dealmakers

PrivatePrivate EquityAcquisitionDomesticMinority

target

Hutchison China Meditech

bidder

Bpea Eqt

£72m

dealmakers

Cross BorderAcquisitionMajorityPublicPrivate EquityTender Offer

target

Vectura Group

bidder

Philip Morris International

£1b

dealmakers

PrivateAcquisitionMajorityCross Border

target

BIOVISION

bidder

Abcam

£244m

dealmakers

China

Private EquityPrivateMajorityDomesticAcquisition

target

Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company

bidder

Gl Capital Group

£127m

dealmakers

Cross BorderAcquisitionMajorityPrivate

Health Care Facilities

target

Gyroscope Therapeutics

bidder

Novartis

£1,1b

dealmakers

Private EquityCross BorderVenture CapitalPrivateMinorityAcquisition

Medical Equipment

target

Omass Therapeutics

bidder

Oxford University Clinic

£75m

dealmakers

PrivateMinorityDomesticPrivate EquityVenture CapitalAcquisition

target

Swanbio Therapeutics

bidder

Syncona

£45m

dealmakers

MajorityAcquisitionCross BorderPublic

Health Care Facilities

target

Mediclinic International

bidder

Remgro

£3,3b

dealmakers

AcquisitionMajorityPublicDomestic

target

F-STAR

bidder

Invox Pharma

£131m

dealmakers

Cross BorderAcquisitionTender OfferPublicMajority

target

Applied Genetic Technologies Corporation

bidder

Syncona

£64m

dealmakers

PrivateMajorityDomesticAcquisition

target

Eleusis Therapeutics

bidder

Beckley Psytech

value n/a

dealmakers

Netherlands

Cross BorderPrivate EquityAcquisitionMajorityPrivate

target

Neogene Therapeutics

bidder

Astrazeneca

£264m

dealmakers

Telecommunications Services: Other

MajorityPrivate EquityPublicDomesticAcquisition

target

Medica Group

bidder

Ik Partners

£269m

dealmakers

MinorityPrivateDomesticAcquisition

target

Quell Therapeutics

bidder

Astrazeneca

value n/a

dealmakers

Cross BorderMinorityPrivateAcquisitionPrivate Equity

target

Beacon Therapeutics

bidder

Syncona

£96m

dealmakers

AcquisitionPublicDomesticMajorityScheme

target

Freeline Therapeutics

bidder

Syncona

£11m

dealmakers

MergerPublicAcquisitionDomesticMajority

target

Karuna Therapeutics

bidder

Bristol Myers Squibb Company

£10b

dealmakers

Private EquityPrivateAcquisitionMinorityCross BorderVenture Capital

target

Apollo Therapeutics

bidder

Patient Square Capital

£179m

dealmakers

DomesticAcquisitionMajorityPrivate

Digital Services

target

Virtual Therapeutics

bidder

Akili Interactive Labs

value n/a

dealmakers

AcquisitionDomesticMinorityPrivatePrivate EquityVenture Capital

target

Beacon Therapeutics

bidder

Syncona

£134m

dealmakers

Private EquityDomesticMajorityAcquisitionPrivate

target

Yellowstone Biosciences

bidder

Syncona

£16m

dealmakers